Evaluation of the new active Bacillus sphaericus strain 2362 in the product Vectolex WG Biological Larvicide

This publication provides a summary of the data reviewed and an outline of the regulatory considerations for the proposed registration of VECTOLEX WG BIOLOGICAL LARVICIDE, which contains the new active constituent Bacillus sphaericus strain 2362. The product is proposed to be used for the control of certain first to early fourth instar mosquito larvae in a range of mosquito breeding situations. 

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.